Abstract Background Treatments in the phase of metastatic castration-resistant prostate cancer (mCRPC) aim to prolong survival and reduce the symptom burden. The fast development o
Single pediatric case report describing a novel application of tunneled epidural analgesia in terminal cancer pain; demonstrates feasibility and tolerability but lacks comparative data and generalizability.
A scoping review synthesizing existing literature on referral criteria without empirical testing of effectiveness; identifies criteria for potential guideline development but lacks implementation data or outcome validation.